Spring Scientific Meeting

(Complimentary hot breakfast included)
Presented by Kerr Russell, PLC
*This session is not eligible for AMA PRA Category 1 Credit™ or ABIM MOC credit.

OBJECTIVES:

1. Describe the new diagnostic platforms for the diagnosis of infectious diseases.
2. Discuss point of care and rapid detection of pathogens in clinical samples.
3. Explain risk factors for invasive candidiasis in ICU patients.
4. Identify novel clinical species of Candida seen in the U.S.
5. List current management strategies of candidiasis.
6. Describe the importance of Antimicrobial Stewardship in the treatment of infections.
7. Discuss areas of inappropriate antimicrobial use and common pitfalls during treatment of infections.

COURSE DIRECTOR:
Sorabh Dhar, MD, Associate Professor of Medicine, Wayne State University School of Medicine; and Medical Director of Infection Prevention/Hospital Epidemiology and Antimicrobial Stewardship, John D. Dingell VA Medical Center

SPEAKERS:
Hossein Salimnia, PhD, ABMM, Professor of Pathology, Wayne State University School of Medicine

   Infectious Diseases and the Evolution of Diagnostic Tests

Sanjay G. Revankar, MD, FIDSA, Professor of Medicine, Director, I.D. Fellowship Program, Division of Infectious Diseases, Wayne State University School of Medicine

    Fungal Infections for the Internist

Doctor Dhar

   Incorporating Antimicrobial Stewardship Principles into Your Daily Practice

OBJECTIVES:

1. Identify patients with asthma based on an understanding of epidemiologic data.
2. Apply a systematic approach to evaluating patients with suspected asthma.
3. Discuss best practices in the accurate diagnosis of asthma.
4. Explain current treatment recommendations of asthma for adults and children.
5. List new treatments available for asthma.

COURSE DIRECTOR: 
Martin Dubravec, MD, Allergy & Asthma Specialists of Cadillac

  Epidemiology of Asthma
Diagnosis and Approach to Management
New Treatments for Asthma

OBJECTIVES:

1. Discuss common types of multiple sclerosis.
2. Describe basic treatment options and recent new medications.
3. Identify common types of involuntary movements.
4. Explain common treatment options for common types of tremors such as Parkinson’s disease and essential tremors.
5. Describe different headache types.
6. Discuss commonly available headache treatment options and recent new medications.
7. Identify neurological presentations that warrant neurocritical care.
8. Explain recent stroke guidelines.

COURSE DIRECTOR: 
Rohit Marawar, MD, Assistant Professor of Neurology, Wayne State University School of Medicine

SPEAKERS:
Evanthia Bernitsas, MD, Associate Professor of Neurology; Director, Multiple Sclerosis Center, Wayne State University and Detroit Medical Center

   Multiple Sclerosis

Edwin George, MD, Assistant Professor of Neurology; Director, Parkinson’s Disease Center, Wayne State University and Detroit Medical Center

   Movement Disorders

Maher Fakhouri, MD, Assistant Professor of Neurology; Wayne State University and Detroit Medical Center

   Headache

Shishir Rao, MD, Neurocritical Care Fellow, Henry Ford Hospital

   Stroke and Other Neurocritical Care

1. Describe the case for integrated behavioral health services in primary care, including the evidence for collaborative care.
2. Discuss principles of integrated behavioral health care.
3. Describe the roles in an integrated care team.
4. Apply a primary care-oriented approach to psychiatric consultation for common behavioral health presentations.

COURSE DIRECTOR: 
Angie Pinheiro, JD, MD, Michigan Psychiatric Society

SPEAKER:

Lori Raney, MD, Principal, Health Management Associates, Denver, Colorado

 Applying the Integrated Care Approach: Practical Skills for the Consulting Psychiatrist and Primary Care Providers

* This course is held in collaboration with the American Psychiatric Association and Michigan Psychiatric Society to provide participants with the practical skills needed to work in collaborative care.

 

Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the American Psychiatric Association (APA). The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians.

 

Designation Statement:

The APA designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This course is not eligible for ABIM MOC credit.

OBJECTIVES: 

1. Identify opportunities and resources available to start referring patients to local Diabetes Prevention Programs.
2. Describe the patient experience in the Diabetes Prevention Program.
3. Describe how this looks in practice with real success story.

 

SPEAKERS:

Tamah Gustafson, MPH, CPH, CHES, Diabetes Prevention Program Coordinator, Michigan Department of Health and Human Services

Dara Barrera, Manager, Practice Management and Health Information Technology, MSMS

OBJECTIVES: 

1. Describe the limitations of skin biopsy.
2. Discuss the importance of clinical information.
3. Express the importance of immunofluorescence.
4. Distinguish the utility of genetic tests.
5. Identify when to order lab testing.
6. Explain underlying pathogenesis of psoriasis with clinically relevant targets.
7. Apply best practices in skin cancer prevention and photoprotection.
8. List treatments for psoriasis.
9. Discuss co-morbid conditions associated with psoriasis.

COURSE DIRECTOR:
Steve Daveluy, MD, Assistant Professor, Department of Dermatology, Wayne State University School of Medicine

SPEAKERS:
Darius Mehregan, MD, Hermann Pinkus Chairman of Dermatology and Associate Professor, Wayne State University School of Medicine

   Diagnosing Difficult Rashes

Geoffrey Potts, MD, Dermatologist, University Physician Group Dermatology

   Updates in Psoriasis

Doctor Daveluy

   Sun Protection and Skin Cancer in 2019

OBJECTIVES:

1. Discuss the definition, causes of Acute Coronary Syndrome (ACS).
2. Explain the diagnosis and management of ACS.
3. Discuss appropriate strategy for patients with cardiogenic shock.
4. Use of team-based treatment strategies to optimize outcomes for patients with cardiogenic shock.
5. Identify the growing incidence and importance of Atrial Fibrillation (AF) in the population.
6. Discuss the use of anticoagulation in AF for stroke prevention.
7. Summarize pharmacologic and non-pharmacologic options for AF management.

COURSE DIRECTOR: 
Mansoor A. Qureshi, MD, FACC, Director Research and Co-Director Cardiac Catheterization Lab, St. Joseph Mercy Health System

SPEAKERS:
Erik Howell MD, FACC, Cardiologist, St. Joseph Mercy Health System and Michigan Heart

Acute Coronary Syndrome

Tanmay Swadia MD, FACC, Cardiologist, ‎St. Joseph Mercy Health System and Michigan Heart

 

Cardiogenic Shock 

Shrinivas Hebsur MD, FACC, Cardiologist, Clinical Cardiac Electrophysiologist, ‎St. Joseph Mercy Health System and Michigan Heart

   

Early Intervention in Atrial Fibrillation

Doctor Qureshi

Transcatheter Aortic Valve Replacement: Information for the Clinician and the Patient

OBJECTIVES:

1. Analyze the need for patient assessment of pain management medications.
2. Assess barriers to change.
3. Recognize a balance between pain management and overuse of medications.
4. Outline CDC Guidelines.
5. Describe the new opioid law and its impact.

SPEAKER: 
Carl Christensen, MD, PhD, D-FASAM, FACOG, cMRO, Clinical Associate Professor, Departments of Psychiatry and OB Gyn, Wayne State University School of Medicine

OBJECTIVES:

1. Discuss blockchain technology (no technical background required).
2. Describe records ownership, and how it differs from other forms of ownership.
3. Explain privacy and security considerations.

SPEAKER:
Natalie Smolenski, Anthropologist and SVP Business Development, Learning Machine, Dallas, Texas

OBJECTIVES:

1. Discuss emerging data related to the cardiovascular safety of SGLT2 inhibitors.
2. Discuss clinical application of emerging cardiovascular safety data related to SGLT2 inhibitors and what is forthcoming in the future.
3. Describe best practices on how to care for the underinsured and non-insured patients who have diabetes.
4. Explain continuous glucose monitoring (CGM) with usual care among patients with type 1 diabetes (T1D)
5. Evaluate the cost-effectiveness of CGM among patients with T1D.
6. Discuss appropriate use of newer glucose-monitoring technology.

COURSE DIRECTOR: 
Arti Bhan, MD, FACE, Division Head, Endocrinology, Henry Ford Health System

SPEAKERS:

Shiri Levy, MD, Senior Staff Physician and Service Chief of Endocrinology,

Henry Ford West Bloomfield Hospital

     New and Emerging SGLT-2 inhibitor Cardiovascular Outcome Trial (CVOT) Data

Sharon Lahiri, MD, Senior Staff Physician Director, Endocrinology Fellowship Program, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Hospital 

    Continuous Glucose Monitoring

Doctor Bhan

   How to Care for the Underinsured and Non-Insured Patients Who Have Diabetes